Diffuse toxic goiter
Graves' disease (GD), also known as toxic diffuse goiter or Basedow's disease, is an organ-specific autoimmune disease with increased secretion of thyroid hormone (TH). The clinical manifestations are not limited to the thyroid gland, but a multi-system syndrome, including: hypermetabolic syndrome, diffuse goiter, eye signs, skin lesions and thyroid acromegaly. Since most patients have both hypermetabolism and thyroid enlargement, it is called toxic diffuse goiter, also known as Graves' disease. The manifestations outside the thyroid gland are infiltrative endocrine exophthalmos, which can exist alone without hypermetabolism.
-
Site of disease:
thyroid -
Infectious :
Not contagious -
Frequent population:
More common in young and middle-aged people -
Related symptoms:
Mental allergy excitability anxiety tension depression -
Concurrent disease:
Related Drugs
Propylthiouracil Enteric-coated Tablets
Indication: It is used for various types of hyperthyroidism, including toxic diffuse goiter (Graves' disease). In Graves' disease, it is especially suitable for: 1. Patients with mild disease and mild to moderate thyroid enlargement; 2. Children, adolescents and elderly patients; 3. Patients with recurrence after thyroid surgery but not suitable for radioactive 131I treatment; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy
Propylthiouracil Enteric-coated Tablets
Indication: It is used for various types of hyperthyroidism, including toxic diffuse goiter (Graves' disease). In Graves' disease, it is especially suitable for: 1. Patients with mild to moderate thyroid enlargement; 2. Children, adolescents and elderly patients; 3. Patients with recurrence after thyroid surgery but not suitable for radioactive 131I treatment; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy.
Manufacturer:
Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
Propylthiouracil Enteric-coated Capsules
Indication: It is used for various types of hyperthyroidism, including toxic diffuse goiter (Graves' disease). In Graves' disease, it is especially suitable for: 1. Patients with mild to moderate thyroid enlargement; 2. Children, adolescents and elderly patients; 3. Patients with recurrence after thyroid surgery but not suitable for radioactive 131I treatment; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy.
Manufacturer:
Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
Propylthiouracil Enteric-coated Capsules
Indication: It is used for various types of hyperthyroidism, including toxic diffuse goiter (Graves' disease). In Graves' disease, it is especially suitable for: 1. Patients with mild disease and mild to moderate thyroid enlargement; 2. Children, adolescents and elderly patients; 3. Patients with recurrence after thyroid surgery but not suitable for radioactive 131I treatment; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy
Related Ingredients